6533b831fe1ef96bd1298ec6
RESEARCH PRODUCT
In vivo and ex vivo magnetic resonance spectroscopy of the infarct and the subventricular zone in experimental stroke
Andrés Jurado-rodríguezMyriam DavilaSara Gil-perotinJosé Manuel García-verdugoJoan Martí-fàbregasAna Paula CandiotaCarles ArúsSilvia Lope-piedrafitaRaquel Delgado-mederosElena Jiménez-xarriésubject
In vivo magnetic resonance spectroscopyBrain InfarctionMalePathologymedicine.medical_specialtyMRSspectroscopyMagnetic Resonance SpectroscopyTime FactorsHRMASSubventricular zoneRats Sprague-DawleyIn vivoLateral VentriclesmedicineAnimalsStrokebusiness.industryNeurogenesismedicine.diseasestrokeNeural stem cellRatsStrokeneurogenesisDisease Models Animalmedicine.anatomical_structureNeurologyBiomarker (medicine)Original ArticleNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessNeuroscienceEx vivoBiomarkersdescription
Ex vivo high-resolution magic-angle spinning (HRMAS) provides metabolic information with higher sensitivity and spectral resolution than in vivo magnetic resonance spectroscopy (MRS). Therefore, we used both techniques to better characterize the metabolic pattern of the infarct and the neural progenitor cells (NPCs) in the ipsilateral subventricular zone (SVZi). Ischemic stroke rats were divided into three groups: G0 (non-stroke controls, n = 6), G1 (day 1 after stroke, n = 6), and G7 (days 6 to 8 after stroke, n =12). All the rats underwent MRS. Three rats per group were analyzed by HRMAS. The remaining rats were used for immunohistochemical studies. In the infarct, both techniques detected significant metabolic changes. The most relevant change was in mobile lipids (2.80 ppm) in the G7 group (a 5.53- and a 3.95-fold increase by MRS and HRMAS, respectively). In the SVZi, MRS did not detect any significant metabolic change. However, HRMAS detected a 2.70-fold increase in lactate and a 0.68-fold decrease in N-acetylaspartate in the G1 group. None of the metabolites correlated with the 1.37-fold increase in NPCs detected by immunohistochemistry in the G7 group. In conclusion, HRMAS improves the metabolic characterization of the brain in experimental ischemic stroke. However, none of the metabolites qualifies as a surrogate biomarker of NPCs.
year | journal | country | edition | language |
---|---|---|---|---|
2015-01-21 |